| Financial Year |
March 31 2023 |
| Monetary Funds |
65,647,370.60 |
| Held-for-trading Financial Assets |
344,772,226.03 |
| Notes Receivable |
7,599,353.02 |
| Accounts Receivable |
106,242,802.93 |
| Advances to Suppliers |
4,312,326.63 |
| Other Receivables |
581,913.22 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
129,303,113.40 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
16,109,719.64 |
| Total Current Assets |
760,204,852.95 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
536,462,929.26 |
| Under-construction Projects |
124,401,163.88 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
17,418,970.64 |
| R&D expenses |
-- |
| Goodwill |
1,605,654.22 |
| Long-Term Deferred and Prepaid Expenses |
9,808,077.37 |
| Deferred Income Tax Assets |
1,542,661.39 |
| Other Non-Current Assets |
9,162,254.05 |
| Sub-Total of Non-Current Assets |
701,224,738.04 |
| Total Assets |
1,461,429,590.99 |
| Short-Term Loans |
11,471,050.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
50,190,000.00 |
| Accounts Payable |
67,966,594.50 |
| Accounts Received In Advance |
116,891.32 |
| Employee Compensation Payable |
5,293,569.04 |
| Taxes Payable |
6,980,071.18 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
945,370.09 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
228,664.92 |
| Other Current Liabilities |
751,742.30 |
| Sub-Total of Current Liabilities |
150,271,581.01 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,072,246.50 |
| Total Liabilities |
153,343,827.51 |
| Paid-In Capital(Or Share Stock) |
144,000,000.00 |
| Capital Surplus |
877,167,130.52 |
| Surplus Reserve |
32,155,994.41 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
234,700,468.56 |
| Minority Stockholder's Interest |
18,319,342.74 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,289,766,420.74 |
| Owner's Equity（Stockholder's Equity） |
1,308,085,763.48 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,461,429,590.99 |
